Loading institutional data...
Loading institutional data...
Held by 784 of 6,047 reporting institutions (98th percentile) — extremely crowded.
Data as of Q2 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $3.27B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Insufficient data. Current ROIC on all capital: 12%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Interest last disclosed in FY2022 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-12
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.76B 100.0% | $3.69B 100.0% | $3.24B 100.0% | $2.88B 100.0% | $2.29B 100.0% | $1.75B 100.0% | $1.43B 100.0% | $1.22B 100.0% | $1.09B 100.0% | $964.8M 100.0% |
| Selling, General & Admin | $996.1M 20.9% | $736.5M 20.0% | $660.1M 20.4% | $695.3M 24.1% | $444.2M 19.4% | $259.0M 14.8% | — | — | — | — |
| Total Operating Expenses | $4.71B 99.0% | $2.94B 79.6% | $2.80B 86.5% | $2.75B 95.5% | $3.41B 149.0% | $1.45B 82.7% | $1.46B 102.1% | $870.4M 71.4% | $1.50B 138.7% | $1.02B 105.4% |
| Interest Expense | — | — | — | $71.4M 2.5% | $36.8M 1.6% | $24.9M 1.4% | — | — | $21.2M 2.0% | $18.0M 1.9% |
| Other Income (Expense), net | $394.2M 8.3% | $329.3M 8.9% | $499.0M 15.4% | $204.4M 7.1% | $263.7M 11.5% | $65.9M 3.8% | $122.5M 8.6% | $96.2M 7.9% | $174.7M 16.1% | $60.0M 6.2% |
| Pretax Income | $1.29B 27.1% | $1.28B 34.6% | $1.33B 41.2% | $510.8M 17.7% | $1.07B 46.6% | $379.5M 21.6% | $425.2M 29.7% | $184.3M 15.1% | $149.9M 13.8% | $297.9M 30.9% |
| Income Tax Expense | $198.5M 4.2% | $164.6M 4.5% | $173.0M 5.3% | $71.9M 2.5% | $147.4M 6.4% | $55.0M 3.1% | $52.4M 3.7% | $32.2M 2.6% | -$23.1M -2.1% | $11.0M 1.1% |
| Net Income | $426.1M 9.0% | $441.0M 11.9% | $474.3M 14.7% | $167.5M 5.8% | $386.7M 16.9% | $152.1M 8.7% | $148.9M 10.4% | $57.0M 4.7% | $76.2M 7.0% | $111.8M 11.6% |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
The same 2 years as the 3-yr average, with the stock compensation of those years charged as a cost. Shares issued to employees are real dilution, so this asks what the business generates for existing holders.
To be worth $118.15 today, the market must believe free cash flow compounds 3.6%/yr for a decade (off $2.48B on the SBC-adjusted basis).
On the basis ($3.03B) the requirement is 0.6%/yr. The difference is what charging stock compensation costs.
The market's 3.6% is in line with its 1-yr track record.
Default is 12.7% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.23B shares (market data) · net debt $0
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 26 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-06-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BX | $85.8B | 29.5× | — | 5.9× | 9.2% | — | 20.9% | 34.8% | 14.2% | — | 2,080 |
| APO | $70.1B | 21.4× | — | 2.2× | 22.7% | — | 10.9% | 15.0% | 9.5% | — | — |
| AMP | $44.2B | 13.8× | — | 2.3× | 5.5% | — | 18.8% | 54.4% | 54.4% | — | 1,335 |
| ARES | $26.7B | — | — | 5.6× | 28.9% | — | 11.1% | 12.3% | 12.3% | — | 784 |
| TROW | $22.4B | 11.4× | — | 3.1× | 3.1% | — | 28.5% | 19.2% | 19.2% | — | 1,123 |
| BEN | $16.3B | 35.2× | 25.5× | 1.9× | 3.5% | — | 6.0% | 4.3% | 3.6% | 3.2× | 648 |
| CG | $13.7B | 17.6× | 8.7× | 2.9× | -11.9% | — | 16.9% | 11.5% | 11.5% | -1.5× | 572 |
| EVR | $10.5B | 19.4× | — | 2.7× | 29.5% | — | 15.3% | 29.1% | 29.1% | — | 677 |
| AMG | $10.0B | 17.0× | — | 4.8× | 1.6% | — | 34.5% | 22.1% | 12.1% | — | 543 |
| HLI | $9.1B | 20.9× | 13.9× | 3.5× | 9.5% | — | 16.3% | 18.2% | 18.2% | -2.1× | 493 |
| MORN | $7.7B | 23.1× | 11.5× | 3.1× | 7.5% | 61.0% | 15.3% | 30.6% | 16.3% | 0.8× | 403 |
| TPG | $7.5B | 100.6× | 11.7× | 1.6× | 33.4% | — | 4.0% | 4.5% | 3.2% | 1.2× | 359 |
| VCTR | $6.9B | 27.6× | 14.0× | 5.3× | 46.2% | — | 25.3% | 13.6% | 9.7% | 1.5× | 345 |
| OWL | $6.5B | 94.9× | 20.1× | 11.4× | 7.6% | — | 13.9% | 3.6% | 1.4% | 6.5× | 569 |
| FHI | $4.2B | 11.0× | 7.6× | 2.3× | 10.3% | — | 22.4% | 33.7% | 26.1% | -0.5× | 376 |
| LAZ | $3.6B | 16.9× | 10.5× | 1.1× | 1.5% | — | 7.4% | 27.2% | 9.3% | 0.6× | 336 |
| CNS | $3.6B | 23.3× | 18.2× | 6.4× | 7.5% | — | 27.6% | 27.3% | 27.3% | -0.8× | 304 |
| APAM | $2.4B | 8.3× | 6.3× | 2.0× | 7.6% | — | 24.3% | 66.2% | 46.2% | 0.5× | 361 |
| RPC | $875M | 46.7× | 18.1× | 2.9× | 0.3% | — | 6.6% | 4.8% | 2.5% | 5.1× | — |
| VRTS | $869M | 6.6× | 5.4× | 1.0× | -6.0% | — | 15.9% | 14.6% | 10.3% | 1.7× | 231 |
| GCMG | $807M | 31.4× | 7.2× | 1.4× | 8.5% | — | 8.1% | 168% | 10.0% | 1.4× | 142 |
| ABX | $801M | 22.8× | 10.9× | 3.4× | 110% | 87.7% | 15.5% | 8.7% | 4.4% | 3.4× | 148 |
| NOAH | $520M | 32.9× | — | 1.4× | 4.8% | — | 21.4% | 5.7% | 5.7% | — | 88 |
| HKHC | $382M | 75.9× | 28.3× | 5.2× | 30.5% | — | 7.0% | 1.5% | 1.5% | -3.0× | 1 |
| WHG | $181M | 23.9× | 28.2× | 1.9× | 3.2% | — | 7.2% | 5.6% | 5.6% | -4.8× | 71 |
Peers = companies sharing ARES's sector (Investment Advice) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-12
Where each multiple sits in its own 12-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 12% against ROIC 12% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 13.5% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| SG&A | — | — | 14.8 | 19.4 | 24.1 | 20.4 | 20.0 | 20.9 |
| Income Tax | 2.6 | 3.7 | 3.1 | 6.4 | 2.5 | 5.3 | 4.5 | 4.2 |
| Net Income | 4.7 | 10.4 | 8.7 | 16.9 | 5.8 | 14.7 | 11.9 | 9.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ARES: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | not reported | 11.6% |
| FY2017 | not reported | not reported | 7.0% |
| FY2018 | not reported | not reported | 4.7% |
| FY2019 | not reported | not reported | 10.4% |
| FY2020 | not reported | not reported | 8.7% |
| FY2021 | not reported | not reported | 17.9% |
| FY2022 | not reported | not reported | 5.8% |
| FY2023 | not reported | not reported | 14.7% |
| FY2024 | not reported | not reported | 12.6% |
| FY2025 | not reported | not reported | 11.1% |
Return on equity (12%) and return on invested capital (12%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Cash conversion of 0.20x sits below the level that would make the earnings clearly cash-backed.
Reported free cash flow is $3.27B; after share-based compensation it is $2.53B. The difference is a real cost that the cash flow statement adds back.
No debt, so there is no leverage path to distress.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
At $117.22, free cash flow must compound 3.46%/yr for 10 years. It has no positive compounding record after stock compensation to compare against, though across a reporting-basis change.
The achieved growth rate spans a reporting-basis change in FY2021, so part of it measures the restatement rather than the business.
| Step | Amount | Running total |
|---|---|---|
| Net income | $527M | $527M |
| Share-based comp | $741M | $1.27B |
| Other non-cash & working capital | $2.00B | $3.27B |
| Operating cash flow | $3.27B | $3.27B |
| Capex | $0 | $3.27B |
| Free cash flow | $3.27B | $3.27B |
| FCF after SBC | $2.53B | $2.53B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 22.4% | not reported | not reported |
| FY2021 | 30.5% | not reported | not reported |
| FY2022 | 25.8% | not reported | not reported |
| FY2023 | 12.4% | not reported | not reported |
| FY2024 | 14.0% | not reported | not reported |
| FY2025 | 28.9% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | 18.6 percent |
| FY2020 | 3.8 percent |
| FY2021 | 13.9 percent |
| FY2022 | 4.1 percent |
| FY2023 | 2.9 percent |
| FY2024 | -9.3 percent |
| FY2025 | -9.6 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.